课题基金 / 基金详情

Emory Alzheimer's Disease Research Center

Emory Alzheimer's Disease Research Center
埃默里阿尔茨海默病研究中心
批准号:
10884532
负责人:
ALLAN I LEVEY
金额:
$1.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-07-15 至 2025-04-30
关键词:
Academic Medical CentersAccelerationAction ResearchAddressAdvocateAffectAfrican AmericanAfrican American populationAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAreaAutopsyAwarenessBiological MarkersBiological Specimen BanksBloodBrainBrain imagingCaringClinicClinicalClinical ResearchClinical TrialsClinical Trials Support UnitCollaborationsCommunitiesComplementDNADataData ScientistDedicationsDementiaDevelopmentDiseaseDisparityEarly identificationEducationFacultyFamily CaregiverFosteringFoundationsFundingGeneticGoalsGrantHealth ProfessionalHeterogeneityImageIndividualIndividual DifferencesInstitutionInterventionLeadershipLinkMemoryOutcomeParticipantPathogenicityPersonal SatisfactionPilot ProjectsPlasmaPlayPreventionProteinsProteomicsPublic HealthPublicationsRaceRecommendationResearchResearch ActivityResearch PersonnelResearch SupportResourcesRiskRisk FactorsRoleSamplingScientistSpecial PopulationSpecimenSpinal CordTeacher Professional DevelopmentTrainingTranslatingTranslational ResearchTranslationsUnderrepresented MinorityUnited States National Institutes of HealthUniversitiesVariantWorkbasebuilt environmentburden of illnesscaregivingcaregiving researchclinical practicecohortcommunity partnershipdata managementdesigndiversity and inclusioneducation researcheffective therapyempowermentethnoracialfaculty mentorhealthy agingimprovedinnovationmemory careminority engagementmultidisciplinaryneuropathologynext generationnoveloutreachprogramsrecruitresearch studyresponsesuccesssupportive environmentsymposiumtherapeutic targettraining opportunity

项目摘要

项目成果

ALLAN I LEVEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT: OVERALL The Goizueta Alzheimer’s Disease Research Center (ADRC) at Emory University provides Georgia and the region with comprehensive clinical, research, and educational programs. This application outlines our success in building an environment that encourages and supports innovative projects with a central theme of discovery and translation of new biomarkers and pathogenic mechanisms to enable early identification, intervention, and ultimately prevention of AD and related disorders. Given the well documented disparities in clinical research participation and burden of disease for AD in the African American community, the Goizueta ADRC dedicates effort and resources to help better understand and address inter-individual differences in AD and ADRD, ranging from ethno-racial factors to individual differences in genetic and protein variation. We benefit from generous institutional support from Emory, one of the nation’s fastest growing research academic medical centers, the generous Atlanta community, and a large and highly collaborative interdisciplinary team of more than 100 faculty across Emory and local institutions. Our cores work in a concerted manner to effectively recruit, evaluate, and engage a diverse cohort of participants who actively take part in a wide variety of research studies. The addition of a Minority Engagement Core helps to further engage special populations, most notably the African American community, to help the Outreach, Recruitment and Engagement Core and Clinical Core with an ambitious goal of 50% African American participation in the UDS cohort. Our Biomarker Core provides state-of-the-art genetic, proteomic, and brain imaging analyses, complemented by an extensive biospecimen repository of well-characterized blood, CSF, and DNA samples, and a large bank of well- characterized postmortem brains and spinal cords in the Neuropathology Core. These valuable resources will continue to be distributed widely for a variety of approved studies, including research Developmental Projects and in support of local and national collaborations. Generous institutional and philanthropic support is used to seed a much larger base of innovative research. The ADRC educational programs reach a broad audience of trainees, researchers, health care professionals, and the public. New to us with this application, the Research Education Component will help formalize our longstanding dedication to the cultivation of the next generation of scientists. With a strong commitment to diversity and inclusiveness, our program benefits from the engagement of a large and multidisciplinary core of training faculty mentors from institutions throughout the greater Atlanta area. Collectively, the ADRC is poised to continue to make important contributions to the national strategy for AD treatment and prevention.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1126/sciadv.abc5802
发表时间: 2020-10
期刊: Science advances
影响因子: 13.6
作者: [Zhang Q, Ma C, Chin LS, Li L]
通讯作者: Li L
DOI: 10.3233/jad-215431
发表时间: 2022
期刊: JOURNAL OF ALZHEIMERS DISEASE
影响因子: 4
作者: [Hone-Blanchet, Antoine, Bohsali, Anastasia, Krishnamurthy, Lisa C., Shahid, Salman S., Lin, Qixiang, Zhao, Liping, Bisht, Aditya S., John, Samantha E., Loring, David, Goldstein, Felicia, Levey, Allan, Lah, James, Qiu, Deqiang, Crosson, Bruce]
通讯作者: Crosson, Bruce
Prevalence of suspected dementia in a sample of adults living in Kinshasa-Democratic Republic of the Congo.
居住在刚果民主共和国金沙萨的成年人样本中疑似痴呆症的患病率。
DOI: 10.1002/alz.13003
发表时间: 2023
期刊: Alzheimer's & dementia : the journal of the Alzheimer's Association
影响因子: --
作者: [Ikanga,Jean, Reyes,Anny, Kaba,Didine, Akilimali,Pierre, Mampunza,Samuel, Epenge,Emmanuel, Gikelekele,Guy, Kavugho,Immaculee, Tshengele,Nathan, Hammers,DustinB, Alonso,Alvaro]
通讯作者: Alonso,Alvaro
Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease.
阿尔茨海默病中富含肝素的血浆蛋白质组发生显着改变。
DOI: 10.21203/rs.3.rs-3933136/v1
发表时间: 2024
期刊: Research square
影响因子: --
作者: [Guo,Qi, Ping,Lingyan, Dammer,EricB, Yin,Luming, Xu,Kaiming, Shantaraman,Anantharaman, Fox,EdwardJ, Golde,ToddE, Johnson,ErikCB, Roberts,BlaineR, Lah,JamesJ, Levey,AllanI, Seyfried,NicholasT]
通讯作者: Seyfried,NicholasT
22
    Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
    • 批准号:
      10514142
    • 项目类别:
    • 资助金额:
      $164.1万
    • 财政年份:
      2022
    • 负责人:
      ALLAN I LEVEY
    • 依托单位:
    Novel Protein Biomarkers of Corticolimbic Pathophysiology in Lewy body Dementia
    • 批准号:
      10704614
    • 项目类别:
    • 资助金额:
      $160.63万
    • 财政年份:
      2022
    • 负责人:
      ALLAN I LEVEY
    • 依托单位:
    Emory Alzheimer's Disease Research Center
    • 批准号:
      10408020
    • 项目类别:
    • 资助金额:
      $64.33万
    • 财政年份:
      2020
    • 负责人:
      ALLAN I LEVEY
    • 依托单位:
    Emory Alzheimer's Disease Research Center
    • 批准号:
      10673933
    • 项目类别:
    • 资助金额:
      $288.47万
    • 财政年份:
      2020
    • 负责人:
      ALLAN I LEVEY
    • 依托单位:
    海外基金